Oragenics, Inc. is a development-stage company that is focused on fighting infectious diseases, including those caused by coronaviruses and multidrug-resistant organisms. The Company’s lead product NT-CoV2-1 is an intranasal vaccine candidate to prev... اقرأ أكثر
skynewsarabia.com
almaghribtoday.net
cnnbusinessarabic.com
almaghribtoday.net
احصل على تحليلات مفصلة للأسهم من LSEG تتضمن السعر المستهدف بحسب رأي المحللين.